These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 15777645)

  • 1. Scaffold-based bone engineering by using genetically modified cells.
    Hutmacher DW; Garcia AJ
    Gene; 2005 Feb; 347(1):1-10. PubMed ID: 15777645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human bone marrow stromal cells: In vitro expansion and differentiation for bone engineering.
    Ciapetti G; Ambrosio L; Marletta G; Baldini N; Giunti A
    Biomaterials; 2006 Dec; 27(36):6150-60. PubMed ID: 16965811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Runx2 genetic engineering and in vitro maturation of tissue-engineered constructs on the repair of critical size bone defects.
    Byers BA; Guldberg RE; Hutmacher DW; García AJ
    J Biomed Mater Res A; 2006 Mar; 76(3):646-55. PubMed ID: 16287095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells.
    Zhang ZY; Teoh SH; Chong MS; Schantz JT; Fisk NM; Choolani MA; Chan J
    Stem Cells; 2009 Jan; 27(1):126-37. PubMed ID: 18832592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel hydroxyapatite/chitosan bilayered scaffold for osteochondral tissue-engineering applications: Scaffold design and its performance when seeded with goat bone marrow stromal cells.
    Oliveira JM; Rodrigues MT; Silva SS; Malafaya PB; Gomes ME; Viegas CA; Dias IR; Azevedo JT; Mano JF; Reis RL
    Biomaterials; 2006 Dec; 27(36):6123-37. PubMed ID: 16945410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving concepts in bone tissue engineering.
    Cowan CM; Soo C; Ting K; Wu B
    Curr Top Dev Biol; 2005; 66():239-85. PubMed ID: 15797456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal cells for skeletal tissue engineering.
    Panetta NJ; Gupta DM; Quarto N; Longaker MT
    Panminerva Med; 2009 Mar; 51(1):25-41. PubMed ID: 19352307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone engineering with adipose tissue derived stromal cells.
    Weinzierl K; Hemprich A; Frerich B
    J Craniomaxillofac Surg; 2006 Dec; 34(8):466-71. PubMed ID: 17157521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
    Mauney JR; Volloch V; Kaplan DL
    Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of partially demineralized osteoporotic cancellous bone matrix combined with human bone marrow stromal cells for tissue engineering: an in vitro and in vivo study.
    Liu G; Sun J; Li Y; Zhou H; Cui L; Liu W; Cao Y
    Calcif Tissue Int; 2008 Sep; 83(3):176-85. PubMed ID: 18704250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macroporous scaffolds associated with cells to construct a hybrid biomaterial for bone tissue engineering.
    Rosa AL; de Oliveira PT; Beloti MM
    Expert Rev Med Devices; 2008 Nov; 5(6):719-28. PubMed ID: 19025348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix-mediated retention of in vitro osteogenic differentiation potential and in vivo bone-forming capacity by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
    Mauney JR; Kirker-Head C; Abrahamson L; Gronowicz G; Volloch V; Kaplan DL
    J Biomed Mater Res A; 2006 Dec; 79(3):464-75. PubMed ID: 16752403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically engineered mesenchymal stem cells: The ongoing research for bone tissue engineering.
    Hong D; Chen HX; Ge R; Li JC
    Anat Rec (Hoboken); 2010 Mar; 293(3):531-7. PubMed ID: 20027644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State of the art and future directions of scaffold-based bone engineering from a biomaterials perspective.
    Hutmacher DW; Schantz JT; Lam CX; Tan KC; Lim TC
    J Tissue Eng Regen Med; 2007; 1(4):245-60. PubMed ID: 18038415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Runx2 overexpression enhances osteoblastic differentiation and mineralization in adipose--derived stem cells in vitro and in vivo.
    Zhang X; Yang M; Lin L; Chen P; Ma KT; Zhou CY; Ao YF
    Calcif Tissue Int; 2006 Sep; 79(3):169-78. PubMed ID: 16969589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroviral-mediated gene therapy for the differentiation of primary cells into a mineralizing osteoblastic phenotype.
    Phillips JE; García AJ
    Methods Mol Biol; 2008; 433():333-54. PubMed ID: 18679633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periosteal cells in bone tissue engineering.
    Hutmacher DW; Sittinger M
    Tissue Eng; 2003; 9 Suppl 1():S45-64. PubMed ID: 14511470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-engineered bone formation with cryopreserved human bone marrow mesenchymal stem cells.
    Liu G; Shu C; Cui L; Liu W; Cao Y
    Cryobiology; 2008 Jun; 56(3):209-15. PubMed ID: 18430412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological and biophysical principles in extracorporal bone tissue engineering. Part I.
    Meyer U; Joos U; Wiesmann HP
    Int J Oral Maxillofac Surg; 2004 Jun; 33(4):325-32. PubMed ID: 15145032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of xylosyltransferase I correlate with the mineralization of the extracellular matrix during osteogenic differentiation of mesenchymal stem cells.
    Müller B; Prante C; Gastens M; Kuhn J; Kleesiek K; Götting C
    Matrix Biol; 2008 Mar; 27(2):139-49. PubMed ID: 17980567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.